ADPT
#1448
Adaptive Biotechnologies Corporation - Common Stock
25.5 7 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.47%
Variación mensual
+5.40%
Variación en los últimos 6 meses
+99.30%
Cambio anual
+48.15%
Cierres anteriores
26.4 9
Open
26.3 1
Mínimo
24.7 6
Máximo
26.3 6
Financials
- Market Capitalization 4.08 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-41.64
Relación precio/flujo de caja
8.9
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1367 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 81.57 USD | -0.97% | -7.91% | -24.72% | +136.02% | 4.56 B USD | ||
| 1432 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 38.45 USD | -1.56% | -5.44% | -12.57% | +152.46% | 4.18 B USD | ||
| 1450 |  TNGX Tango Therapeutics, Inc. - Common Stock | 24.17 USD | +1.51% | +4.36% | +0.79% | +233.38% | 4.08 B USD | ||
| 1474 |  RLAY Relay Therapeutics, Inc. - Common Stock | 17.98 USD | +0.56% | -7.79% | -5.12% | +172.42% | 3.94 B USD |